Keros Therapeutics, Inc. (KROS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading KROS…

Keros Therapeutics, Inc. (KROS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Keros Therapeutics, Inc.

KROS · CIK 1664710

4 · Feb 20, 2026 · Regnante Keith sold 4,739 shares at $16.35/share ($77,483)

4

Regnante Keith sold 4,739 shares at $16.35/share ($77,483)

Filed: Feb 20, 2026
Accession: 0001682068-26-000003
Filer: Keros Therapeutics, Inc.

View on SEC.gov All SEC filings

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.